tirzepatide adolescent obesity trial Lilly Decides to Advance for Tirzepatide (ZEPBOUND) Approved for Chronic

Rybelsus is the only oral GLP-1 option approved for type 2 diabetes

UnitedHealthcare vs Aetna/CVS Caremark Aetna uses CVS Caremark for pharmacy benefits

Some people, particularly those still in the titration phase or those sensitive to gastrointestinal effects, report mild increases in nausea

To access the podcast and all formats go to hubermanlab.com keep in mind that the website is highly searchable in the sense that you can put any term/s into the search function, and it will take you to the specific time stamp in mind across all episodes, newsletters, etc

However, not everyone will need to be on a higher dose to see significant weight loss